UBS reaffirms its ‘buy’ recommendation on Reckitt Benckiser with a price target raised to 8400 8700 pence, a new target which implies a potential upside of 33% for the title of the British hygiene and health products group.
“The superior resilience of Reckitt’s business model and evidence of an enhanced ability to gain share point to consistent operational outperformance,” the broker said in its note summary.
Copyright (c) 2022 CercleFinance.com. All rights reserved.
The information and analyzes disseminated by Cercle Finance only constitute a decision-making aid for investors. Cercle Finance cannot be held liable directly or indirectly following the use of information and analyzes by readers. It is recommended that any uninformed person consult a professional adviser before any investment. This indicative information does not in any way constitute an incitement to sell or a solicitation to buy.